SNORD13D

Across TCGA pan-cancer cohorts, SNORD13D RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNORD13D’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where SNORD13D RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORD13D is over-expressed in tumor.

BLCA, HNSC, and ESCA are the cancer types where SNORD13D tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORD13D RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.281	.009	3	view →
HNSC	All	III,IV	+0.117	.020	3	view →
ESCA	All	II,III,IV	+0.779	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SNORD13D–BLCA

Open the BLCA breakdown →